These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 8750273)
1. T cell reconstitution by haploidentical BMT does not restore the diversification of the Ig heavy chain gene in patients with X-linked SCID. Minegishi Y; Ishii N; Tsuchida M; Okawa H; Sugamura K; Yata J Bone Marrow Transplant; 1995 Dec; 16(6):801-6. PubMed ID: 8750273 [TBL] [Abstract][Full Text] [Related]
2. Preferential utilization of the immature JH segment and absence of somatic mutation in the CDR3 junction of the Ig H chain gene in three X-linked severe combined immunodeficiency patients. Minegishi Y; Okawa H; Sugamura K; Yata J Int Immunol; 1994 Nov; 6(11):1709-15. PubMed ID: 7865464 [TBL] [Abstract][Full Text] [Related]
3. Intrinsic defects of B cell function in X-linked severe combined immunodeficiency. White H; Thrasher A; Veys P; Kinnon C; Gaspar HB Eur J Immunol; 2000 Mar; 30(3):732-7. PubMed ID: 10741387 [TBL] [Abstract][Full Text] [Related]
4. X-linked SCID and other defects of cytokine pathways. Uribe L; Weinberg KI Semin Hematol; 1998 Oct; 35(4):299-309. PubMed ID: 9801259 [TBL] [Abstract][Full Text] [Related]
5. T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency. Smogorzewska EM; Brooks J; Annett G; Kapoor N; Crooks GM; Kohn DB; Parkman R; Weinberg KI Arch Immunol Ther Exp (Warsz); 2000; 48(2):111-8. PubMed ID: 10807052 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the CDR3 region of the rearranged IgH chain genes in patients with severe combined immunodeficiency and severe lymphopenia. Minegishi Y; Akagi K; Nishikawa K; Okawa H; Yata J J Immunol; 1996 Jun; 156(12):4666-71. PubMed ID: 8648110 [TBL] [Abstract][Full Text] [Related]
7. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model. Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919 [TBL] [Abstract][Full Text] [Related]
8. Ig heavy chain CDR3 size diversities are similar after conventional peripheral blood and ex vivo expanded hematopoietic cell transplants. Gokmen E; Bachier C; Raaphorst FM; Muller T; Armstrong D; LeMaistre CF; Teale JM Bone Marrow Transplant; 2001 Feb; 27(4):413-24. PubMed ID: 11313671 [TBL] [Abstract][Full Text] [Related]
9. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation]. Fu YW; Wu DP; Sun AN; Feng YF; Chang WR; Zhu ZL; Zhu P Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):312-7. PubMed ID: 17877159 [TBL] [Abstract][Full Text] [Related]
10. Impairment of ligand binding and growth signaling of mutant IL-2 receptor gamma-chains in patients with X-linked severe combined immunodeficiency. Ishii N; Asao H; Kimura Y; Takeshita T; Nakamura M; Tsuchiya S; Konno T; Maeda M; Uchiyama T; Sugamura K J Immunol; 1994 Aug; 153(3):1310-7. PubMed ID: 8027558 [TBL] [Abstract][Full Text] [Related]
11. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Puel A; Ziegler SF; Buckley RH; Leonard WJ Nat Genet; 1998 Dec; 20(4):394-7. PubMed ID: 9843216 [TBL] [Abstract][Full Text] [Related]
12. Postnatal development of T cells in dogs with X-linked severe combined immunodeficiency. Somberg RL; Tipold A; Hartnett BJ; Moore PF; Henthorn PS; Felsburg PJ J Immunol; 1996 Feb; 156(4):1431-5. PubMed ID: 8568244 [TBL] [Abstract][Full Text] [Related]
13. B cell function after haploidentical in utero bone marrow transplantation in a patient with severe combined immunodeficiency. Bartolomé J; Porta F; Lafranchi A; Rodríguez-Molina JJ; Cela E; Cantalejo A; Fernández-Cruz E; Gómez-Pineda A; Ugazio AG; Notarangelo LD; Gil J Bone Marrow Transplant; 2002 Apr; 29(7):625-8. PubMed ID: 11979315 [TBL] [Abstract][Full Text] [Related]
14. [Molecular genetics of X-linked primary immunodeficiencies: advances in diagnosis and prevention]. Carbonara A; Brusco A; Carbonara C Ann Ital Med Int; 1996; 11(3):180-6. PubMed ID: 8998263 [TBL] [Abstract][Full Text] [Related]
15. Selective growth advantage of wild-type lymphocytes in X-linked SCID recipients. Kume A; Koremoto M; Mizukami H; Okada T; Hanazono Y; Sugamura K; Ozawa K Bone Marrow Transplant; 2002 Jul; 30(2):113-8. PubMed ID: 12132050 [TBL] [Abstract][Full Text] [Related]
16. Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency. Wengler GS; Allen RC; Parolini O; Smith H; Conley ME J Immunol; 1993 Jan; 150(2):700-4. PubMed ID: 8093460 [TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb. Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111 [TBL] [Abstract][Full Text] [Related]
18. Reconstitution of gammadelta T cell repertoire diversity after human allogeneic hematopoietic cell transplantation and the role of peripheral expansion of mature T cell population in the graft. Hirokawa M; Horiuchi T; Kawabata Y; Kitabayashi A; Miura AB Bone Marrow Transplant; 2000 Jul; 26(2):177-85. PubMed ID: 10918428 [TBL] [Abstract][Full Text] [Related]
19. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome. Razanajaona D; van Kooten C; Lebecque S; Bridon JM; Ho S; Smith S; Callard R; Banchereau J; Brière F J Immunol; 1996 Aug; 157(4):1492-8. PubMed ID: 8759730 [TBL] [Abstract][Full Text] [Related]
20. Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy. Otsu M; Anderson SM; Bodine DM; Puck JM; O'Shea JJ; Candotti F Mol Ther; 2000 Feb; 1(2):145-53. PubMed ID: 10933924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]